POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE emailed Poly Medicure on January 7, 2026, seeking clarification on a significant increase in trading volume of the company's shares across exchanges. The company responded that there is no undisclosed price-sensitive information or pending announcement that could explain the unusual volume movement. The company stated that the trading activity is purely market-driven and not linked to any material corporate development. The company also reaffirmed its ongoing compliance with SEBI's Listing Obligations and Insider Trading regulations. This is a routine exchange query, not a regulatory action against the company.
Neutral for shareholders. The company has proactively confirmed there is no hidden negative news behind the volume spike, which may reassure investors. However, the unusual volume itself warrants continued monitoring for any subsequent disclosures.